Please assess the completion status of the following clinical trial:

Trial Title: Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Confirmed diagnosis of 1 of the following:~  * Acute myeloid leukemia (AML), meeting any of the following criteria:~    * Relapsed disease~   * AML arising from myelodysplastic syndromes~   * Primary refractory disease~   * De novo AML with high-risk features~ * Acute lymphoblastic leukemia (ALL), meeting any of the following criteria:~    * De novo ALL that is Philadelphia chromosome positive or with t(4,11) cytogenetic features~   * Relapsed disease~ * Multiple myeloma (in need of treatment)~* Planning to undergo HLA-matched related sibling nonmyeloablative hematopoietic stem cell transplantation~PATIENT CHARACTERISTICS:~* Not specified~PRIOR CONCURRENT THERAPY:~* See Disease Characteristics

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).